Introduction
Influenza A virus is a worldwide pathogen that induces pathological changes throughout the entire respiratory tract. The infection can result in a spectrum of clinical responses ranging from asymptomatic infection to severe primary viral pneumonia that can rapidly progress to a fatal outcome. The most severe significant pathological alterations are present in the lower respiratory tract, characterized by acute diffuse inflammation of the larynx, trachea and bronchi. The typical uncomplicated influenza syndrome is a tracheobronchitis with additional involvement of small airways (Little et al., 1976) . Viral antigen is present predominantly in epithelial cells and mononuclear cells, but it is also infrequently found in the basal cell layer Peschke et al., 1993) . Young children, elderly and patients with cardiopulmonary disease represent the classical high-risk patients (Olshaker, 2003) .
Influenza A virus represents the prototype of the Orthomyxoviridae in the order of Mononegavirales. The segmented negative strand genome encodes for at least 10 different viral proteins. The function of these proteins is well characterized (Palese et al., 1996; Scholtissek, 1997; Steinhauer and Skehel, 2002) . The coding capacity of influenza A virus genome is relatively small. Therefore, virus replication is dependent on various host cell functions . Recently, we were able to demonstrate that caspase 3 activation, a process involved in the regulation of apoptosis, is essential for influenza virus propagation (Wurzer et al., 2003) . Moreover, influenza A virus infection leads to a biphasic activation of the Raf/MEK/ERK signalling cascade. Inhibition of this pathway by the use of specific MEK inhibitors results in a nuclear retention of viral nucleoprotein complex (RNP) and impaired function of the nuclear export protein NEP/NS2. Consequently, production of influenza virus is inhibited . The Raf/MEK/ERK signalling cascade is the prototype of the family of mitogen-activated protein kinases (MAPK) and is involved in cell proliferation, differentiation and survival. The Raf kinase and its upstream activator, the small GTPase Ras, are highly oncogenic in their active form and a mutated form of the Ras GTPase is frequently found in naturally occurring lung tumors (Bos, 1989) . Lung-targeted expression of the C-Raf kinase under control of SP-C promotor, to allow the expression of the transgene in type II epithelial cells lining the lung alveoli, results in multicentric alveolar adenomas (Kerkhoff et al., 2000) .
Here, we addressed the question if influenza A virus infection of mice expressing active Raf under the control of a lung-specific promoter leads to alteration in the pathology and clinical outcome. We show that infection of mice with influenza A virus (FPV, Fowl Plague Virus) results in more severe clinical symptoms and in a dosedependent increase of mortality as compared to wild-type mice. Immunohistology revealed a different localization of the influenza virus infection in the lung of Raf-BxB mice compared to wild-type mice. More infected alveolarepithelial cells, bearing the Raf-BxB transgene, were found which may be the cause of increased mortality.
Results

Influenza A virus replication in MDCK cells with altered Raf/MEK/ERK signalling pathway
In earlier studies, we have demonstrated that influenza A virus replication is impaired when Raf/MEK/ERK signalling pathway was blocked using a MEK-specific inhibitor . To further investigate this phenomenon, MDCK cells were transfected with different constructs expressing dominant-negative forms of Raf (C4B, BxB301) or ERK2 (C3, B3) kinases and subsequently infected with influenza virus (FPV). Although transfection rates of these MDCK cells were approximately 60%, a significant reduction of virus titers was observed (Figure 1a) . In contrast, when MDCK cells expressing constitutive active Raf or MEK were used for FPV infection, virus replication was increased (Figure 1b) . In addition to the earlier observation that an impaired Raf/MEK/ERK pathway leads to reduced influenza virus replication, the results demonstrate that activation of the pathway results in an increase of virus titer.
Survival rates of Raf-BxB and C57Bl/6 mice after influenza virus infection
To examine the in vivo relevance that influenza A virus replication is increased in cells with an upregulated Raf/ MEK/ERK pathway, transgenic mice were used for influenza A virus infection expressing the oncogenically activated NH 2 -terminal deletion mutant c-raf-1-BxB under the control of the human SP-C promotor. This allows the expression in type II epithelial cells lining the lung alveoli. The C-Raf kinase is a downstream effector of Ras signalling. Both Ras and Raf proteins are highly oncogenic when they are mutationally activated, and are mutated frequently in naturally occurring tumors (Bos, 1989; Mercer and Pritchard, 2003) . Consequently, in the lung of Raf-BxB, single tumor foci are detectable in the alveolar area already at the age of 8 weeks, which develop to solid tumors (Kerkhoff et al., 2000) . Histological Lung-specific expression of active Raf kinase V Ölschläger et al analyses of lung tissues from a 4-month-old C57Bl/6 wild-type mouse revealed normal lung tissue morphology (Figure 2a ), whereas in 4-month-old mice transgenic for lung-targeted expression of Raf-BxB proteins either few isolated small tumor foci were found (Figure 2b ) or the animals harbored multiple tumor foci in the alveolar epithelium ( Figure 2c ). Furthermore, to show that the ERK pathway is activated in Raf-BxB induced adenomas, ERK phosphorylation was demonstrated by immunohistology using a phospho-ERK (pERK)-specific antibody. While pERK is detectable in the alveolar area and adenomas of 4-month-old BxB mice (Figure 2d ), only few single alveolar-epithelial cells showed pERK in age-matched C57Bl/6 control animals ( Figure 2e ). To investigate the influence of targeted Raf-BxB overexpression on influenza A virus replication, wildtype and Raf-BxB mice were infected with three different virus doses of Fowl Plague Virus (A/FPV/ Bratislava/79), a mouse adapted avian influenza A virus that is pathogenic in mice. Infection with 10 6 PFU (plaque-forming units) represents a roughly 100-fold lethal dose. In addition, however, infectious doses of 10 4 and 10 2 PFU were used. The latter represents a virus dose that is normally controlled by wild-type mice. After infection with 10 2 PFU FPV, wild-type mice developed disease symptoms, but all mice survived. In contrast, infection of Raf-BxB mice with the same virus dose resulted in 20% death (Figure 3a) . The disease symptoms found in Raf-BxB mice were more severe as compared to the controls. After infection with 10 4 PFU of FPV, onset of disease was very rapid in Raf-BxB mice and all mice died between days 6 and 9 after infection, whereas infection of C57Bl/6 resulted in delayed onset of the disease and about 30% of the animals survived the virus challenge ( Figure 3b ). In contrast, when animals were infected with 10 6 PFU of FPV no PFU FPV resulted in rapid onset of disease in Raf-BxB mice and all mice died between days 6 and 9 after infection, whereas infection of C57Bl/6 resulted in delayed onset of disease and about 30% of the animals survived the virus challenge. A total of 10 mice were used in each group. The experiments were repeated twice with similar results
Lung-specific expression of active Raf kinase V Ölschläger et al difference of general health status, onset of clinical symptoms and death rate was found (data not shown).
Virus titers in lungs of infected Raf-BxB mice and wild-type C57Bl/6 mice To investigate the basis for higher susceptibility of RafBxB mice to influenza A virus infection, mice were infected with 10 4 PFU FPV. Between days 1 and 8 post infection (p.i.), six wild-type and six Raf-BxB mice were killed daily. Influenza virus titers in the lung of Raf-BxB mice and C57Bl/6 mice were determined in a 10% homogenate of the complete lung of each individual animal. Already 24 h p.i. a massive accumulation of influenza A virus is detectable in the lungs of Raf-BxB and C57Bl/6 mice. Until day 4 p.i., virus titers in the lung increased by around 1.5 log 10 . During an observation period of 8 days, the virus titer in the lung of RafBxB mice and wild-type C57Bl/6 mice revealed no significant difference, although individual high titers were found in some Raf-BxB mice ( Figure 4 ).
Mortality rate was not altered in Raf-BxB mice compared to C57Bl/6 mice after infection with Pseudorabies virus
Since no differences were found in virus titers between Raf-BxB and C57Bl/6 mice, the question remained why Raf-BxB mice were more susceptible to influenza A virus infection. Therefore, we addressed the question whether possibly the general health status or the immune status of Raf-BxB mice is altered, due to effects of tumor development and questioned whether Raf-BxB mice properly respond against another viral pathogen. To test the ability of Raf-BxB mice to control a viral infection in general, transgenic and wild-type mice were infected with different doses of Pseudorabies virus (PRV). After intramuscular infection, Pseudorabies virus migrates intra-axonally to the central nervous system and leads to dose-dependent death of infected mice (Card and Enquist, 1995) . Consequently, Pseudorabies virus-induced pathogenesis is independent of the lung. When Raf-BxB mice and C57Bl/6 mice were infected with either 3 Â 10 2 , 10 2 or 3 Â 10 1 PFU PRV, no difference in virus dose-dependent mortality was observed (Table 1) . To further investigate the capacity of the immune system to control viral infections in RafBxB mice, the animals were immunized with a Parapoxvirus vector bearing the gene encoding glycoprotein gC of PRV. To compare protection of BxB and wild-type mice, both groups only received a single immunization that does result in 100% protection from PRV infection (Fischer et al., 2003) . After 7 days, the animals were challenged with PRV. All animals were protected against lethal PRV challenge infection. Furthermore, no differences in glycoprotein gC-specific IgG1 (8.970.9/8.371.0Àlog 2 ) and IgG2a (7.770.9/ 7.770.9 Àlog 2 ) titers were found when sera of five individual C57Bl/6 and BxB mice were tested (Table 1) . These results indicate that the immune system of BxB mice is similar to wild-type mice with regard to protection against a viral infection.
Different tissue distribution of influenza A virus in RafBxB mice compared to C57Bl/6 mice after infection
Since the health status and the immune system of RafBxB mice was not significantly altered compared to C57Bl/6 mice, it was still puzzling why influenza virus infection in Raf-BxB mice results in higher mortality rates. Expression of the c-Raf transgene in type II alveolarepithelial cells leads to cell proliferation resulting in a massive tumor formation. Therefore, immunohistological analyses were performed to monitor the tissue distribution of influenza virus in wild-type and Raf-BxB mice, by the use of a nucleoprotein-specific antibody. At day 3 p.i. with 10 4 PFU of FPV, NPpositive reactions were detectable in bronchiolar epithelial cells, indicating ongoing virus propagation. Already at this early time point p.i., massive virusinduced destruction of the epithelial layer was found in both groups with no differences in the amount of antigen expression (Figure 5 a, b) . Massive influenza A virus infection was found in the alveolar layers of RafBxB mice, exactly where the c -raf-1 transgene is expressed (Figure 5c ). In contrast, only a few single alveolar cells were infected in parental C57Bl/6 mice ( Figure 5d ). Until day 6 p.i., staining of influenza NPpositive cells in the lower airways increased in almost all Raf-BxB mice (Figure 5e ), while an increase of Figure 4 Production of infectious virus (FPV) in the lung of RafBxB mice (black bars) and C57Bl/6 mice (white bars). Six mice of each strain were infected with 10 4 PFU FPV intra nasal and were killed at different time points as indicated. Lung virus titers were determined using standard plaque assay as described in Methods section Lung-specific expression of active Raf kinase V Ölschläger et al NP-positive cells in the alveolar tissue of C57Bl/6 was a rather rare event (not shown). Most interestingly, a massive infection of tumor foci was found at this time point (Figure 5f ). To demonstrate that influenza A virus was present in the same cells where Raf overexpression was found, 4-month-old BxB mice were infected with 10 4 PFU FPV, and at day 6 p.i., the lungs were taken for histological analysis. Serial sections of the lungs were either stained in immunohistology with a Raf-specific antibody (Figure 6 
Discussion
In the present study, the in vivo impact of constitutive signalling via the Raf/MEK/ERK signalling pathway on influenza A virus propagation and disease was investigated. The Raf/MEK/ERK kinase cascade plays an important role in cell proliferation and differentiation. Activation of the Raf kinase by Ras is the first step in the activation of the Raf/MEK/ERK cascade. Both Ras and Raf are key regulatory proteins in cellular transformation (Marshall, 1995) . Mutated Ras and constitutive activation of the Raf/MEK/ERK signalling cascade is found in many human lung tumors (Naumann et al., 1997; Ramakrishna et al., 2000) . Nevertheless, the exact role of Ras and Raf in lung tumor development remains to be elucidated (Ramakrishna et al., 2000) .
Influenza virus propagation is strongly dependent on the cellular machinery, in particular on the Raf/MEK/ ERK signalling cascade Pleschka et al., 2001; Ludwig et al., 2003) . Inhibition of this pathway by a specific MEK inhibitor significantly reduced the production of infectious virus . Consequently, the question was raised as to how influenza virus replication is influenced in cells where the Raf/MEK/ERK signalling pathway is permanently activated. Indeed, we observed a significant increase of virus production in cells transiently expressing constitutively active Raf or MEK. Keeping in mind that the transfection rate was only about 60% and thus These results not only demonstrate that specific inhibition of the cascade interferes with virus propagation but also shows that selective and permanent activation leads to enhanced virus titers. Thus, in addition to the data provided in earlier experiments with MEK inhibitors , the present study further demonstrates that influenza A virus propagation in vitro is strongly dependent on the activation status of the Raf/MEK/ERK signalling pathway.
These results prompted us to test the concept in an animal model. We chose the Raf-BxB transgenic mouse model since in these mice an activated form of the Raf kinase is expressed in the lung, which is the genuine site of an influenza virus infection. Lung-targeted expression of the oncogenically activated c-Raf-1 protein was achieved by the use of a human SP-C promoter, allowing selective expression in type II epithelial cells lining the lung alveoli (Korfhagen et al., 1990) . Owing to the oncogenic nature of the transgene, these mice rapidly develop lung adenomas (Kerkhoff et al., 2000) . Already at the age of 1 month, the mice start to develop single tumor foci in the alveolar tissue (Kerkhoff et al., 2000) . In the present study, transgenic mice were infected with influenza A virus around 4 months of age. At this stage, multiple tumor foci were visible in the lung of Raf-BxB mice. Influenza infection of Raf-BxB mice and agematched controls with 10 4 PFU resulted in a rapid onset of disease and an increased death rate compared to control mice. It should be mentioned that upon infection with very high doses (10 6 PFU) of FPV, Raf-BxB mice and control animals died at the same time and with comparable disease symptoms (data not shown). However, this high-dose infection represents a situation were the lung is swamped with virus which simply overrides activating effects. Consequently, a big difference between Raf-BxB and control cannot be expected.
One might argue that the side effects of the tumor in these animals do not allow the mice to generate a potent immunological response against a viral infection as wildtype mice can do. To investigate this concern, Raf-BxB mice and control C57Bl/6 mice were infected with Pseudorabies virus (PRV), a virus that in mice migrates directly to the brain and causes dose-dependent death in infected mice. Furthermore, a vaccination model using Parapoxvirus vector encoding the gC of PRV was used to test the immune response in Raf-BxB compared to control mice (Fischer et al., 2003) . In both experimental setups, no differences were observed. Thus, at least on the level of immune defence against a virus infection RafBxB mice are equally potent to their parental controls.
To answer the question what the basis for the severity of disease in Raf-BxB mice is, we analysed lung virus titers but were unable to find a significant difference. Nevertheless, with the use of immunohistological staining, we were able to detect increased influenza infection in the alveolar tissue of Raf-BxB mice. Consequently, these cells were targets for cytolytic destruction by influenza virus. Furthermore, we were able to detect massive infection in tumor foci, in areas were the transgene Raf-BxB is expressed. In wild-type C57Bl/6 control mice, influenza A virus (FPV) was more pronounced in the bronchi and bronchiolar-epithelial cells, while infection of the alveolar cells was very rare.
Consequently, we hypothesize that cells expressing Raf-BxB transgene are preferentially targeted by influenza A virus. The massive destruction of type II alveolar-epithelial cells by the lytic virus or by the cellular immune response may thereby result in a severe alveolar damage that is responsible for the higher mortality rate in Raf-BxB mice after influenza virus infection. The fact that lung virus titers are not altered in Raf-BxB mice compared to controls can be explained by the observation that the number of type II alveolarepithelial cells, which are selectively infected in Raf-BxB but not in wild-type mice, is low compared to the number of bronchiolar-epithelial cells infected in both types of animals. Further, one has to consider variations in the animals. Although cell numbers are low, damage of the alveolar epithelium might have more severe consequences for the survival of the animals.
So far we cannot fully rule out that there are additional indirect effects that come to play besides a direct influence of influenza virus propagation on Raf/ MEK/ERK signalling. For instance, the Raf-induced tumor foci may represent an immune-privileged site were virus-infection might only be insufficiently defended. However, so far we do not have any evidence for an altered immune response in Raf-BxB mice, for example, reduced immune cell infiltrates in alveolar tissue.
Until now, the information on the outcome of an influenza virus infection in patients with proliferative diseases is very limited. In general, an increased incidence of influenza infection and a high morbidity rate due to infections with this virus are observed in those patients (Couch et al., 1997; Arrowood and Hayney, 2002) . Furthermore, the symptoms of influenza may not be as severe compared to other individuals, but the duration of the illness tends to be prolonged. This is often due to an impaired humoral and cellular immune response because of chemo-or radiotherapy (Brydak and Machala, 2000) . In contrast, in another study, it was shown that after vaccination, the immune response of lung cancer patients to influenza virus was comparable to that of healthy controls (Anderson et al., 1999) .
Another report revealed influenza virus antigen in autopsy lung tissue specimen from patients with cancer. Each of the patients with demonstrable viral antigens had adequate causes of death demonstrated at autopsy. Nevertheless, the authors of this report believe that diffuse alveolar damage, probably induced by the viral infection, contributed to the death of some patients (Porter and Porter, 1999) . Although several patients with lung carcinoma were included in the study, a direct correlation between increased influenza infections in patients with lung cancer was not found.
In summary, we have shown for the first time in an in vivo model that influenza virus propagation is dependent The findings may also be a basis for novel tumor therapies. The strong tropism of influenza virus for cells with activated Raf suggests that wild-type influenza virus or genetically modified virus mutants (Bergmann et al., 2001 ) may be used as anticancer agents in the future, allowing selective elimination of Ras/Raf-transformed tumor cells.
Materials and methods
Mammalian expression vectors and transfections
The empty expression vector (pKRSPA, empty vector) and plasmids expressing dominant-negative mutants of ERK and Raf (pKRSPA-ERK2B3, pKRSPA-ERK2C3 and pKRSPARafC4B, KRSPA-Raf-BXB301) as well as the construct expressing the active mutant pKRSPA Raf-BxB were described previously (Ludwig et al., 1996) . A constitutively active mutant of MEK1 (pBABE DStu1 MEK1 LIDEMANE) was generated by deletion of an autoinhibitory A-helix and by exchange of two activating phosphorylation sites at position 218/222 to glutamic acid (von Gise et al., 2001) . MDCK cells were transfected with Lipofectamine 2000 (Invitrogen).
Virus and infection
Mouse-adapted avian influenza A/FPV/Bratislava/79 (H7N7) (FPV) virus was used for infection of Madine-Darby canine kidney (MDCK) cells that were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal calf serum (FCS) and antibiotics. Cells were washed with phosphate-buffered saline (PBS) and infected with various virus doses as indicated by the multiplicity of infection (MOI) in PBS/BA (PBS containing 0.2% bovine serum albumin, 1 mM MgCl2, 0.9 mM CaCl 2 , 100 U penicillin/ml, 0.1 mg streptomycin/ml 1 ) for 1 h at room temperature. The inoculum was removed and cells were incubated with DMEM/BA at 371C for various periods of time. A standard plaque assay was used to determine the effect of transiently expressed dominantnegative or constitutively active mutants of Raf and ERK or MEK, respectively, on the production of infectious virus particles at various time points p.i. to assess the number of infectious particles.
Generation and propagation of recombinant Orf virus (ORFV; Parapoxvirus ovis) expressing PRV gC is described in detail (Fischer et al., 2003) . The highly neurotropic Alphaherpesvirus of swine Pseudorabiesvirus (PRV; Herpesvirus suis type 1) strain NIA-3 was propagated and titrated on PSEK cells as described before (Ober et al., 1998) .
Mice
Inbred C57Bl/6 mice were obtained from the animal-breeding facilities at the Bundesforschungsanstalt fu¨r Viruskrankheiten der Tiere (BFAV), Tu¨bingen. Homozygous Raf-BxB mice were obtained from Professor UR Rapp, Wu¨rzburg (Kerkhoff et al., 2000) and bred at the BFAV together with inbred C57Bl/ 6 mice. Heterozygous Raf-BxB mice and wild-type C57Bl/6 mice were infected via the intranasal route with either 10 2 , 10 4 or 10 6 PFU FPV in 20 ml at the age of 4 months. For determination of lung virus titer, mice were killed and lungs were collected in BSS buffer. The samples were homogenized by a Branson Sonifier (10 pulses of 100 W, followed a few minutes later by additional 5 pulses) to obtain a 10% tissue homogenate. The samples were centrifuged at 3000 r.p.m. (5 min) and the supernatant was transferred into Eppendorf cups and stored at À701C.
PRV-specific vaccination and challenge infection
Immunization of mice against PRV was carried out by intramuscular injection of 10 7 TCID 50 (tissue culture infectious dose 50) of the previously described Parapoxvirus ORFV recombinant expressing PRV glycoprotein gC (Fischer et al., 2003) . At 2 weeks after immunization and immediately before challenge infection with 10 3 PFU of PRV NIA-3 (corresponding to 25 LD50), mice were bled from the retroorbital plexus for serum collection.
Sera from immunized and control mice were analysed for PRV-specific IgG1 and IgG2a antibodies by ELISA essentially as described previously (Fischer et al., 2003) . Antibody titers were expressed as negative log2 of the serum dilution exhibiting an at least twofold absorbance than that of the negative control serum that was obtained from nonimmunized mice.
Histology and immunohistology
Immediately after the mice were killed at different time points p.i., lungs were obtained and fixed in buffered 4% paraformaldehyde. All tissues were stained with hematoxylin and eosin. Immunohistochemistry for the detection of Raf was carried out using a rabbit anti-human c-Raf SP63 polyclonal antiserum (1 : 2500) produced at the MSZ in Wu¨rzburg, Germany. Detection of influenza NP was carried out with a goat anti-NP serum (1 : 2500) (G150; a kind gift from Professor R Webster/USA). Prior to the antibody incubation, the slides were blocked with 2.5% rabbit or 2.5% goat serum in PBS for 40 min at RT. Incubation of the primary antibody was performed overnight. Secondary staining was performed with an ABC-kit (Vector) for 30 min at RT. Substrate reaction was performed with DAB kit (Vector). Detection of activated ERK was performed with a pERK-specific rabbit antibody (Cell Signalling; No. 9101) . The slides were blocked with 5% goat serum in PBS for 60 min at RT. Primary antibody incubation (1 : 100) was performed overnight at 41C in a humid chamber. An anti-rabbit biotinlyated secondary antibody (1 : 200) was incubated for 30 min at RT, followed by ABC and DAB (Vector) staining.
